Respiratory disorders

Applied filters

Respiratory disorders

COVID-19 Medicines Optimisation (2)
- COVID-19 Medicines Optimisation: Specialty Guidance (1)
Care Setting (6)
- Paediatrics and neonates (4)
- Primary Care (2)
Events (1)
- Past Event (1)
- Webinars (1)
Guidance (69)
- Advanced therapy medicinal products (1)
- Dosing (1)
- Excipients (1)
- Safety in Breastfeeding (59)
- Stability in dosette boxes (36)
- Stability outside the fridge (8)
Interest areas (1)
- Medicines Safety (1)
Medicine (111)
- Acetylcysteine (1)
- Aclidinium bromide (2)
- Aclidinium bromide + Formoterol (1)
- Acrivastine (2)
- Adrenaline (2)
- Alimemazine (2)
- Aminophylline (3)
- Aspirin (1)
- Ataluren (1)
- Bambuterol (2)
- Beclometasone (3)
- Beclometasone + Formoterol (2)
- Beclometasone + Formoterol + Glycopyrronium bromide (2)
- Bee venom (2)
- Benralizumab (1)
- Beractant (1)
- Bilastine (2)
- Budesonide (4)
- Budesonide + Formoterol (2)
- C1-esterase inhibitor (2)
- Caffeine (1)
- Carbocisteine (2)
- Ceritinib (1)
- Cetirizine (2)
- Chlorphenamine (2)
- Ciclesonide (2)
- Citric acid (2)
- Clemastine (2)
- Codeine (2)
- Colistimethate (1)
- Conestat alfa (2)
- Cyproheptadine (2)
- Dalteparin (1)
- Danazol (1)
- Desloratadine (2)
- Dextromethorphan (2)
- Dornase alfa (2)
- Dupilumab (1)
- Enoxaparin (1)
- Ephedrine (2)
- Epoprostenol (1)
- Erdosteine (1)
- Ethanol (1)
- Fexofenadine (2)
- Fluticasone (3)
- Fluticasone + Formoterol (2)
- Fluticasone + Salmeterol (1)
- Fluticasone + Umeclidinium bromide + Vilanterol (1)
- Fluticasone + Vilanterol (2)
- Formoterol (4)
- Formoterol + Glycopyrronium bromide + Budesonide (1)
- Glycopyrronium (3)
- Grass pollen (2)
- Human alpha1-proteinase inhibitor (1)
- Hydroxyzine (2)
- Icatibant (2)
- Indacaterol (1)
- Indacaterol + Glycopyrronium (1)
- Indacaterol + Mometasone (1)
- Ipratropium (4)
- Ivacaftor (2)
- Ivacaftor + Tezacaftor + Elexacaftor (1)
- Ketotifen (2)
- Levocetirizine (2)
- Loratadine (2)
- Lumacaftor + Ivacaftor (2)
- Mannitol (2)
- Mepolizumab (2)
- Mizolastine (2)
- Molgramostim (1)
- Mometasone (2)
- Mometasone + Glycopyrronium bromide + Indacaterol (1)
- Montelukast (2)
- Nedocromil (2)
- Nintedanib (1)
- Nitric oxide (1)
- Olodaterol (1)
- Omalizumab (2)
- Pholcodine (1)
- Pirfenidone (1)
- Promethazine hydrochloride (2)
- Pseudoephedrine (1)
- Roflumilast (2)
- Rupatadine (2)
- Salbutamol (5)
- Salbutamol + Beclometasone (1)
- Salbutamol + Ipratropium (1)
- Salmeterol (2)
- Sildenafil (1)
- Sirolimus (1)
- Sodium chloride (2)
- Sodium cromoglicate (2)
- Terbutaline (2)
- Tezacaftor + Ivacaftor (1)
- Theophylline (3)
- Tinzaparin (1)
- Tiotropium (2)
- Tiotropium + Olodaterol (1)
- Tobramycin (2)
- Trametinib (1)
- Umeclidinium bromide (3)
- Umeclidinium bromide + Vilanterol (3)
- Wasp venom (2)
- Zafirlukast (2)
Planning (80)
- Biosimilars (1)
- New Medicines (57)
  - CCG commissioned new medicines (33)
  - NHS England commissioned new medicines (24)
  - Pre-registration new medicines (UK/EU) (9)
- Patent expiries (47)
Publications (1)
- Bulletins (1)
- Summary advice (1)
Specialty (126)
- Allergy and immunology (25)
- Anaesthesia and pain (3)
- Cancers (4)
- Cardiovascular system disorders (5)
- Ear, nose and throat disorders (11)
- Endocrine system disorders (1)
- Eyes and vision (6)
- Gastrointestinal disorders (7)
- Haematological disorders (2)
- Infection and infectious diseases (1)
- Mental health and illness (2)
- Musculo-skeletal disorders (2)
- Neurological disorders (2)
- Nutritional and metabolic disorders (1)
- Obstetrics and gynaecology (4)
- Renal and urologic disorders (1)
- Respiratory disorders (126)
- Skin disorders (8)
- Vaccinating (1)

Summary of COVID-19 medicines guidance: Respiratory disorders

30 March 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and respiratory disorders. Our advice…

Safety in Lactation: Drugs for obstructive airways disease

25 September 2020Additional information relating to breastfeeding To be used in conjunction with individual drug entries for specific information and guidance. Bronchodilators Most bronchodilators are considered to…

Safety in Lactation: Mucolytics and other drugs for cystic fibrosis

18 September 2020Additional information relating to breastfeeding To be used in conjunction with individual drug entries for specific information and guidance. There is no evidence to support…

Budesonide + salbutamol

13 September 2020dm+d: 108622005

Is there a role for inhaled epoprostenol, inhaled nitric oxide or sildenafil to treat secondary pulmonary hypertension and hypoxaemia in ICU patients with acute respiratory distress syndrome?

3 July 2020An analysis of pooled randomised controlled trials of the use of inhaled nitric oxide in patients with acute respiratory distress syndrome (ARDS) found no mortality…

SPS - Specialist Pharmacy Service

NHS

Respiratory disorders

126 results

Tanimilast

Summary of COVID-19 medicines guidance: Respiratory disorders

Itepekimab

Depemokimab

Brensocatib

Ensifentrine

Safety in Lactation: Drugs for obstructive airways disease

Safety in Lactation: Mucolytics and other drugs for cystic fibrosis

Budesonide + salbutamol

Is there a role for inhaled epoprostenol, inhaled nitric oxide or sildenafil to treat secondary pulmonary hypertension and hypoxaemia in ICU patients with acute respiratory distress syndrome?

Feedback